Database: MEDLINE (Ovid) (1946 to April week 4, 2012)

1. ((ASA or aspirin or acetylsalicylic or anti platelet or antiplatelet or anti-platelet) adj2 (respons$ or non-respons$ or respond$ or non-respond$ or resistance or resist$)).mp.
2. (platelet adj (response or respond$ or reactivity)).mp.
3. 1 or 2
4. exp Aspirin/
5. exp Drug Resistance/
6. 4 and 5
7. 3 or 6
8. (platelet function adj (analys$ or analyz$)).mp.
9. (platelet function adj (assay$ or test$)).mp.
10. Platelet Function Tests/
11. PFA-100.mp.
12. PlateletWorks.mp.
13. Platelet Mapping.mp.
14. Impact Cone.mp.
15. platelet analyser$.mp.
16. platelet analyzer$.mp.
17. multiplate.mp.
18. aggregometry.mp.
19. LTA.mp.
20. AA-induced LTA.mp.
21. lumiaggregometry.mp.
22. WBA.mp.
23. ULTEGRA assay.mp.
24. Impact-R.mp.
25. TRAP-6.mp.
26. TEG.mp.
27. s-TEG.mp.
28. thromboelastometry.mp.
29. ROTEM.mp.
30. VerifyNow.mp.
31. Verify-Now.mp.
32. VN-RPFA.mp.
33. VASP.mp.
34. VASP-P.mp.
35. platelet reactivity index.mp.
36. vasodilator-stimulated phosphoprotein phosphorylation assay$.mp.
37. T-Guide.tw.
38. T Guide.ti,ab.
39. xylum clot signature analyser.mp.
40. xylum clot signature analyzer.mp.
41. ASA test$.mp.
42. ASA assay$.mp.
43. AA-induced LTA.mp.
44. exp Platelet Count/ or platelet counting.mp.
45. thrombelastography.mp. or Thrombelastography/
46. thrombotic status analyser$.mp.
47. thrombotic status analyzer$.mp.
48. or/8-47
49. exp Cardiovascular Diseases/
50. exp Cerebrovascular Disorders/
51. exp Diabetes Mellitus/
52. or/49-51
53. 48 and 52
54. (predict$ or prognos$).mp.
55. 48 and 54
56. 7 or 53
57. 7 or 55
58. 56 or 57
59. economics/
60. exp “costs and cost analysis”/
61. cost of illness/
62. exp health care costs/
63. economic value of life/
64. exp economics medical/
65. exp economics hospital/
66. economics pharmaceutical/
67. exp "fees and charges"/
68. (econom$ or cost or costs or costly or costing or price or pricing or pharmacoeconomic$).tw.
69. (expenditure$ not energy).tw.
70. (value adj1 money).tw.
71. budget$.tw.
72. decision support techniques/
73. markov.mp.
74. exp models economic/
75. decision analysis.mp.
76. cost benefit analysis/
77. or/59-76
78. 58 and 77

Database: EMBASE (Ovid) (1980 to week 17, 2012)

1. ((ASA or aspirin or acetylsalicylic or anti platelet or antiplatelet or anti-platelet) adj2 (respons$ or non-respons$ or respond$ or non-respond$ or resistance or resist$)).mp.
2. (platelet adj (response or respond$ or reactivity)).mp.
3. 1 or 2
4. exp acetylsalicylic acid/
5. exp drug resistance/
6. 4 and 5
7. 3 or 6
8. (platelet function adj (analys$ or analyz$)).mp.
9. (platelet function adj (assay$ or test$)).mp.
10. PFA-100.mp.
11. PlateletWorks.mp.
12. Platelet Mapping.mp.
13. Impact Cone.mp.
14. platelet analyser$.mp.
15. platelet analyzer$.mp.
16. multiplate.mp.
17. aggregometry.mp.
18. LTA.mp.
19. AA-induced LTA.mp.
20. lumiaggregometry.mp.
21. WBA.mp.
22. ULTEGRA assay.mp.
23. Impact-R.mp.
24. TRAP-6.mp.
25. TEG.mp.
26. s-TEG.mp.
27. thromboelastometry.mp.
28. ROTEM.mp.
29. VerifyNow.mp.
30. Verify-Now.mp.
31. VN-RPFA.mp.
32. VASP.mp.
33. VASP-P.mp.
34. platelet reactivity index.mp.
35. vasodilator-stimulated phosphoprotein phosphorylation assay$.mp.
36. T Guide.mp.
37. T Guide.mp.
38. xylum clot signature analy$.mp.
39. ASA tests$.mp.
40. ASA assay$.mp.
41. AA-induced LTA.mp.
42. platelet counting.mp.
43. thrombelastography.mp. or exp thromboelastography/
44. thrombotic status analy$.mp.
45. or/8-44
46. exp cardiovascular disease/
47. exp cerebrovascular disease/
48. exp diabetes mellitus/
49. or/46-48
50. 45 and 49
51. (predict$ or prognos$).mp
52. 45 and 51
53. 7 or 50
54. 7 or 52
55. 53 or 54
56. cost benefit analysis/
57. cost effectiveness analysis/
58. cost minimization analysis/
59. cost utility analysis/
60. economic evaluation/
61. (cost or costs or costed or costly or costing).tw.
62. (economic$ or pharmacoeconomic$ or price$ or pricing).tw.
63. (technology adj assessment$).tw.
64. decision support.mp.
65. markov.mp.
66. exp statistical model/
67. decision analysis.mp.
68. exp “cost benefit analysis”/
69. or/56-68
70. 55 and 69

Database: The Cochrane Library (Wiley) (NHS Economic Evaluation Database) (2012, issue 2 of 4)

(Search date 4 May 2012.)

#1 (ASA or aspirin or acetylsalicylic or anti next platelet or antiplatelet) near/2 (respon* or non next respon* or resist*)

#2 (platelet) near/1 (response or respond* or reactivity)

#3 (#1 OR #2)

#4 MeSH descriptor Aspirin explode all trees

#5 MeSH descriptor Drug Resistance explode all trees

#6 (#4 AND #5)

#7 (#3 OR #6)

#8 (platelet function) near/1 (analys* or analyz*)

#9 (platelet function) near/1 (assay* or test*)

#10 PFA-100

#11 PlateletWorks

#12 Platelet next Mapping

#13 Cone

#14 platelet next analy*

#15 multiplate

#16 aggregometry

#17 LTA

#18 lumiaggregometry

#19 WBA

#20 ULTEGRA

#21 Impact-R

#22 TRAP-6

#23 TEG

#24 thromboelastometry

#25 ROTEM

#26 VerifyNow

#27 Verify-Now

#28 VN-RPFA

#29 VASP

#30 VASP-P

#31 platelet next reactivity next index

#32 vasodilator next stimulated next phosphoprotein

#33 T next Guide

#34 xylum next clot

#35 (ASA) next (test* or assay*)

#36 AA next induced

#37 platelet next counting

#38 thromboelastography

#39 thrombotic next status next analy*

#40 (#8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39)

#41 MeSH descriptor Cardiovascular Diseases explode all trees

#42 MeSH descriptor Cerebrovascular Disorders explode all trees

#43 MeSH descriptor Diabetes Mellitus explode all trees

#44 (#41 OR #42 OR #43)

#45 (#40 AND #44)

#46 predict* or prognos*

#47 (#40 AND #46)

#48 (#7 OR #45)

#49 (#7 OR #47)

#50 (#48 OR #49)